ABSTRACT
Objective We designed The Irritability and Dysregulation of Emotion Scale (TIDES-13) to test whether irritability consisted of several sub-dimensions that would correlate differentially with internalizing/externalizing psychopathology, age, and gender.
Method Parent-report (n = 3935, mean age = 8.9) and youth self-report (n = 579, mean age = 15.1) versions of TIDES-13 were administered to a population-based sample. Exploratory and confirmatory factor analyses were conducted on separate sub-samples. We fit multivariable regression models between TIDES-13 sub-dimensions and age, gender, anxiety, depression, ODD and ADHD trait levels.
Results A higher order model with a global irritability dimension and Proneness to Anger, Internalized Negative Emotional Reactivity, Externalized Negative Emotional Reactivity and Reactive Aggression sub-dimensions showed good to excellent fit in both parent-report and self-report. The global irritability dimension had a strong influence on all item variance (ωHierarchical; parent report = .0.94, ωHierarchical; self report = .90). Proneness to Anger, Externalized Negative Emotional Reactivity and Reactive Aggression decreased with age in males, whereas Internal Negative Emotional Reactivity increased with age in females. Internalized Negative Emotional Reactivity was associated with internalizing traits, over and above global irritability. ODD and ADHD were predicted primarily by the global irritability.
Conclusion Although irritability can be estimated as an essentially unidimensional construct, differential associations of Internalized Negative Emotional Reactivity with gender and age, and internalizing psychopathology warrant examination in clinical populations. These results support TIDES-13 as a reliable and valid multidimensional measure of irritability and thus may be useful for research and clinical purposes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Canadian Institutes of Health Research (R.J.S., MOP‐93696 and P.D.A., MOP‐106573) and the Alberta Innovates Translational Health Chair in Child and Youth Mental Health (P.D.A.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee of the Hospital for Sick Children gave ethical approval of this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of interest: None.
Data Availability
All data produced in the present study are available upon reasonable request to the authors